发明名称 Carboxylic acid derivatives and drugs containing the same as the active ingredient
摘要 Compounds represented by formula (I), prodrugs thereof and salts thereof, and pharmaceutical compositions comprising the same as an active ingredient (wherein each symbol has the meaning as defined in the specification.). Because of having an EDG-1 agonism, the compounds represented by formula (I) are useful in preventing and/or treating peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid, anal fissure or fistula ani, dissecting aneurysm of the aorta, angina, DIC, pleuritis, congestive heart failure, multiple organ failure, bedsore, burn, chronic ulcerative colitis, Crohn's disease, heart transplantation, renal transplantation, dermal graft, liver transplantation, osteoporosis, pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, liver cirrhosis, chronic renal failure, or glomerular sclerosis.
申请公布号 US7179817(B2) 申请公布日期 2007.02.20
申请号 US20030477106 申请日期 2003.11.10
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 SEKO TAKUYA;TERAKADO MASAHIKO;KOHNO HIROSHI;TAKAHASHI SHINYA
分类号 C07D211/78;A61K31/166;A61K31/167;A61K31/192;A61K31/194;A61K31/196;A61K31/216;A61K31/343;A61K31/381;A61K31/402;A61K31/4184;A61K31/44;A61K31/4402;A61K31/4409;A61K31/5375;A61P1/00;A61P1/04;A61P1/16;A61P9/00;A61P9/10;A61P9/14;A61P11/00;A61P13/12;A61P17/00;A61P17/02;A61P19/10;A61P27/02;A61P29/00;A61P31/04;A61P43/00;C07C49/23;C07C59/68;C07C229/14;C07C229/60;C07C229/62;C07C233/17;C07C233/51;C07C233/73;C07C235/34;C07C235/38;C07C235/66;C07C237/20;C07C237/30;C07C237/32;C07C237/42;C07C311/17;C07C317/00;C07C323/62;C07C323/63;C07C331/00;C07D211/70;C07D213/30;C07D213/40;C07D213/79;C07D213/80;C07D213/82;C07D235/12;C07D295/155;C07D307/60;C07D333/16 主分类号 C07D211/78
代理机构 代理人
主权项
地址